Search - Archive ouverte HAL Access content directly

Filter your results

5 Results
authFullName_s : S. Delaloge

Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational study

S. Delaloge , David Perol , C. Courtinard , E. Brain , B. Asselain et al.
Annals of Oncology, 2016, 27 (9), pp.1725-1732. ⟨10.1093/annonc/mdw260⟩
Journal articles hal-02262350v1

Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights

J.E. Martin , S. Khalife-Hachem , T. Grinda , M. Kfoury , S. Garciaz et al.
Annals of Oncology, 2021, 32 (8), pp.1046-1048. ⟨10.1016/j.annonc.2021.04.015⟩
Journal articles hal-03623367v1

Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial

J. Lemonnier , L. Roca , S. Mijonnet , P. Gesta , J. Chiesa et al.
Familial Cancer, 2012, 11, pp.77-84. ⟨10.1007/s10689-011-9484-4⟩
Journal articles istex hal-02282759v1
Image document

Evolution of overall survival and receipt of new therapies by subtype among 20 446 metastatic breast cancer patients in the 2008-2017 ESME cohort

T. Grinda , A. Antoine , W. Jacot , C. Blaye , P. H. Cottu et al.
ESMO Open, 2021, 6 (3), pp.100114. ⟨10.1016/j.esmoop.2021.100114⟩
Journal articles hal-03273275v1
Image document

Therapy-related myeloid neoplasms following treatment with PARP inhibitors: new molecular insights

J.E. Martin , S. Khalife-Hachem , T. Grinda , M. Kfoury , S. Garciaz et al.
Annals of Oncology, 2021, 32 (8), pp.1046-1048. ⟨10.1016/j.annonc.2021.04.015⟩
Journal articles hal-03376715v1